ADMA Biologics ADMA ADMA Bio Manufacturing — General And Administrative Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's adma bio manufacturing — general and administrative expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's ADMA bio manufacturing — general and administrative expense?
- ADMA Biologics (ADMA) reported ADMA bio manufacturing — general and administrative expense of $8.46M in Q1 2026.
- How has ADMA Biologics's ADMA bio manufacturing — general and administrative expense changed year-over-year?
- ADMA Biologics's ADMA bio manufacturing — general and administrative expense decreased by 0.4% year-over-year, from $8.5M to $8.46M.
- What is the long-term trend for ADMA Biologics's ADMA bio manufacturing — general and administrative expense?
- Over 2 years (2022 to 2024), ADMA Biologics's ADMA bio manufacturing — general and administrative expense has grown at a 18.4% compound annual growth rate (CAGR), from $16.31M to $22.86M.
- What does ADMA bio manufacturing — general and administrative expense mean?
- Includes overhead costs such as executive salaries, legal, accounting, and other corporate support functions allocated to the manufacturing segment. This metric is used to evaluate the operational leverage and cost discipline of the business unit.